Clinical Trial Update: Assessment of Stent Malapposition and Neointimal Coverage on Optical coHerence Tomography at Post-procedure and 3 Months After Platinum Chromium Alloy Of the Element™ Stent Implantation [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update examines malapposition and neointimal coverage after Element platinum-chromium stent implantation using optical coherence tom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Element Stent

Snippet

Sponsor: Yonsei University | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN